Sponsor:
Aseel Alsouqi
Code:
NCT05873712
Conditions
Recurrent Transformed Chronic Lymphocytic Leukemia
Refractory Transformed Chronic Lymphocytic Leukemia
Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Recurrent Transformed Non-Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Marrow Biopsy
Computed Tomography
Cyclophosphamide
Fludarabine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-29. This information was provided to ClinicalTrials.gov by Aseel Alsouqi on 2025-11-24.